Tag: Amylyx

Pricing, Regulations

Amylyx ALS drug draws criticism over $158,000 price tag

October 3, 2022

Via: Pharmaphorum

Amylyx Pharmaceuticals’ Relyvrio – a new treatment for amyotrophic lateral sclerosis (ALS) approved by the FDA on Thursday, after review of the data from its phase 2 trial – was the next day set at a list price of $158,000 […]